During follow-up , good responders to anti-CD3 treatment ( i.e. , IAA ( + ) participants with relatively preserved - cell function [ 25 % of healthy control subjects ] ) experienced a less pronounced insulin-induced rise in I ( A ) A and lower insulin needs .